Stefano Ballestri

Cytowane przez

	Wszystkie	Od 2020
Cytowania	8580	5139
h-indeks	39	30
i10-indeks	57	46

1200

600

300

900

20112012201320142015201620172018201920202021202220232024202559 78 107 153 272 501 671 700 757 1029 1114 1046 919 892 137

Dostęp publiczny

Wyświetl wszystko

3 artykuły

0 artykułów

dostępne

niedostępne

Objęte finansowaniem

Współautorzy

Amedeo LonardoMedicina Interna USL ModenaZweryfikowany adres z ausl.mo.it
Fabio NascimbeniDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, ItalyZweryfikowany adres z unimore.it
Giovanni TargherFull Professor of Endocrinology and Diabetes, University of VeronaZweryfikowany adres z univr.it
Lucia CARULLIZweryfikowany adres z unimore.it
Stefano ZonaAUSL modenaZweryfikowany adres z ausl.mo.it
Alessandro MantovaniDivision of Endocrinology, Diabetes and Metabolism, University and Azienda Ospedaliera UniversitariaZweryfikowany adres z univr.it
Luigi Elio AdinolfiFull Professor of Internal Medicine, Director, University of Campania Luigi Vanvitelli NaplesZweryfikowany adres z unicampania.it
Giulio MarchesiniProfessor of Medicine, University of BolognaZweryfikowany adres z unibo.it
Helena Cortez-PintoClínica Universitária de Gastrenterologia, Faculdade de Medicina, Universidade de LisboaZweryfikowany adres z medicina.ulisboa.pt
C DayNewcastle UniversityZweryfikowany adres z ncl.ac.uk
sebastiano banniProfessor of physiology università di Cagliari, ItalyZweryfikowany adres z unica.it
Fabio MarraProfessor of MedicineZweryfikowany adres z unifi.it
Luca MieleFondazione Pol. Univ. A. Gemelli IRCCS, Università Cattolica Sacro Cuore. RomaZweryfikowany adres z policlinicogemelli.it
Antonio GriecoProfessore associato, Università cattolica del sacro cuore, Facoltà di Medicina e Chirurgia A. Gemelli, RomaZweryfikowany adres z rm.unicatt.it
Claudio TanaInternal Medicine Department, ASL Lanciano Vasto ChietiZweryfikowany adres z asl2abruzzo.it
Giampiero FrancicaPineta Grande Hospital, Castel Volturno (CE), ItalyZweryfikowany adres z pinetagrande.it
Marco MariettaOspedale Policlinico - ModenaZweryfikowany adres z unimore.it
Chiara MasettiDivision of Internal Medicine and Hepatology, Department of Gastroenterology, Humanitas Research Hospital IRCCS, Rozzano, Italy.Zweryfikowany adres z humanitas.it
Ann DalyProfessor of Pharmacogenetics, Newcastle UniversityZweryfikowany adres z ncl.ac.uk
Fabrizio RicciG.d’Annunzio University of Chieti-PescaraZweryfikowany adres z unich.it

Obserwuj

Stefano Ballestri

Azienda USL Modena, Pavullo Hospital

Zweryfikowany adres z ausl.mo.it - Strona główna

Internal Medicine Vascular Medicine Hepatology NAFLD Ultrasound


Tytuł Sortuj wg cytatów Sortuj wg roku Sortuj wg tytułu	Cytowane przez Cytowane przez	Rok
Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps A Lonardo, F Nascimbeni, S Ballestri, DL Fairweather, S Win, TA Than, ... Hepatology 70 (4), 1457-1469, 2019	850	2019
Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome A Lonardo, S Ballestri, G Marchesini, P Angulo, P Loria Digestive and Liver disease 47 (3), 181-190, 2015	825	2015
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and … S Ballestri, S Zona, G Targher, D Romagnoli, E Baldelli, F Nascimbeni, ... Journal of gastroenterology and hepatology 31 (5), 936-944, 2016	794	2016
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes M Ricchi, MR Odoardi, L Carulli, C Anzivino, S Ballestri, A Pinetti, ... Journal of gastroenterology and hepatology 24 (5), 830-840, 2009	751	2009
NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk S Ballestri, F Nascimbeni, E Baldelli, A Marrazzo, D Romagnoli, ... Advances in therapy 34, 1291-1326, 2017	564	2017
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups A Lonardo, S Bellentani, CK Argo, S Ballestri, CD Byrne, SH Caldwell, ... Digestive and Liver Disease 47 (12), 997-1006, 2015	533	2015
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease S Ballestri, A Lonardo, S Bonapace, CD Byrne, P Loria, G Targher World journal of gastroenterology: WJG 20 (7), 1724, 2014	362	2014
Nonalcoholic fatty liver disease and aging: epidemiology to management M Bertolotti, A Lonardo, C Mussi, E Baldelli, E Pellegrini, S Ballestri, ... World journal of gastroenterology: WJG 20 (39), 14185, 2014	348	2014
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study E Villa, R Critelli, B Lei, G Marzocchi, C Cammà, G Giannelli, P Pontisso, ... Gut 65 (5), 861-869, 2016	258	2016
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD S Ballestri, A Lonardo, D Romagnoli, L Carulli, L Losi, CP Day, P Loria Liver International 32 (8), 1242-1252, 2012	230	2012
Cardiovascular risk in non-alcoholic fatty liver disease: mechanisms and therapeutic implications C Tana, S Ballestri, F Ricci, A Di Vincenzo, A Ticinesi, S Gallina, ... International journal of environmental research and public health 16 (17), 3104, 2019	204	2019
The independent predictors of non‐alcoholic steatohepatitis and its individual histological features. Insulin resistance, serum uric acid, metabolic syndrome, alanine … S Ballestri, F Nascimbeni, D Romagnoli, A Lonardo Hepatology Research 46 (11), 1074-1087, 2016	164	2016
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology P Loria, G Marchesini, F Nascimbeni, S Ballestri, M Maurantonio, ... Atherosclerosis 232 (1), 99-109, 2014	153	2014
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV A Lonardo, S Ballestri, G Guaraldi, F Nascimbeni, D Romagnoli, S Zona, ... World journal of gastroenterology 22 (44), 9674, 2016	146	2016
Cardiovascular disease and myocardial abnormalities in nonalcoholic fatty liver disease A Mantovani, S Ballestri, A Lonardo, G Targher Digestive diseases and sciences 61, 1246-1267, 2016	139	2016
Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases S Ballestri, F Nascimbeni, E Baldelli, A Marrazzo, D Romagnoli, ... Metabolism 72, 57-65, 2017	138	2017
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications S Ballestri, D Romagnoli, F Nascimbeni, G Francica, A Lonardo Expert review of gastroenterology & hepatology 9 (5), 603-627, 2015	132	2015
Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen A Lonardo, LE Adinolfi, L Restivo, S Ballestri, D Romagnoli, E Baldelli, ... World journal of gastroenterology: WJG 20 (23), 7089, 2014	120	2014
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? L Carulli, S Ballestri, A Lonardo, F Lami, E Violi, L Losi, L Bonilauri, ... Internal and emergency medicine 8, 297-305, 2013	119	2013
the metabolic syndrome and non‐alcoholic fatty liver disease P Loria, A Lonardo, L Carulli, AM Verrone, M Ricchi, S Lombardini, ... Alimentary pharmacology & therapeutics 22, 31-36, 2005	99	2005

Nie można teraz wykonać tej operacji. Spróbuj ponownie później.

Prace 1–20

Cytowania rocznie

Powielone cytowania

Scalone cytowania

Dodaj współautorówWspółautorzy

Obserwuj

Cytowane przez

Współautorzy